Choose HA†
Prescribing Information   |  OAKneePainRelief.com
GELSYN_header_large_3800x1715

Choose GELSYN-3
for life well-balanced.

  • 3-injection series
  • Consistent lubrication and pain relief
  • Less risk of allergies or sensitivities

GELSYN-3 is manufactured from a non-avian source14

Find a Physician

Choose GELSYN-3 for a life well-balanced

Managing knee osteoarthritis (OA) is like running a marathon. That means finding the right balance of safe pain reduction, improved mobility, and joint protection.

GELSYN-3 delivers hyaluronic acid that’s been formulated to provide lubrication and cushioning benefits, providing joint protection and mobility that may delay the need for surgery, while safely relieving knee pain for up to 6 months.9,12,36

While the study did not include GELSYN-3, the study included evaluation of other 3-injection HA formulations

Learn how GELSYN-3 can help

Get your GELSYN-3 rebate today Get Rebate

Gelsyn-3 Packaging

SUPARTZ-middlesection-landingpage

GELSYN-3 helps you manage your symptoms and reduce knee pain from osteoarthritis, so you can get moving again and keep your life in balance.

GELSYN-3 FAQs

Sign up for KneeMail

Sign up

Enjoy free resources and information about OA knee pain to help you get relief and resume your active life

DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g., acetaminophen. Risks include general knee pain and pain at the injection site.

View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM

Summary of Indications for Use:
DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

DUROLANE has not been tested in pregnant or lactating women, or children.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.